HIV and STD Prevention Update. New CDC Guidelines for HIV Post exposure Prophylaxis

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

HIV and STD Prevention Update. New CDC Guidelines for HIV Post exposure Prophylaxis

Published Date:

August 1998

Status:

superseded

| This document has been replaced by: Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016

Source:

AIDS patient care and STDs. 1998; 12(8):649-53.

Language:

English

[HTML]

This is an HTML document so it cannot be previewed.

To open, click the "View" button.

Details:

Keywords:

[+]

Description:

These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 18 30, 2009. The information in this report updates the 2006 Guidelines for Treatment of Sexually Transmitted Diseases (MMWR 2006;55[No. RR 11]). Included in these updated guidelines is new information regarding 1) the expanded diagnostic evaluation for cervicitis and trichomoniasis; 2) new treatment recommendations for bacterial vaginosis and genital warts; 3) the clinical efficacy of azithromycin for chlamydial infections in pregnancy; 4) the role of Mycoplasma genitalium and trichomoniasis in urethritis/cervicitis and treatment-related implications; 5) lymphogranuloma venereum proctocolitis among men who have sex with men; 6) the criteria for spinal fluid examination to evaluate for neurosyphilis; 7) the emergence of azithromycin-resistant Treponema pallidum; 8) the increasing prevalence of antimicrobial-resistant Neisseria gonorrhea; 9) the sexual transmission of hepatitis C; 10) diagnostic evaluation after sexual assault; and 11) STD prevention approaches.

Document Type:

Journal Article

Collection(s):

Guidelines and Recommendations

Place as Subject:

United States

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016

Personal Author:

Dominguez, Kenneth L.; Smith, Dawn K.; Vasavi Thomas,; Crepaz, Nicole; Lang, Karen; Heneine, Walid; McNicholl, Janet M.; Reid, Laurie; Freelon, Brandi; Nesheim, Steven R.; Huang, Ya-lin (Aileen); Weidle, Paul J.;

Published:

April 18, 2016, Update (May 23, 2018)

Description:

Interim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir – Implications for HIV Post-exposure Prophylaxis (PEP). Please see attached statement (PDF of Dolutegravir attached) : From the Centers for Disease Control and Preventio...

Status:

current

File Type:

[PDF - 1.17 MB]
Preexposure prophylaxis for the prevention of HIV infection in the United States – 2017 update : a clinical practice guideline

Corporate Author:

United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Preexposure Prophylaxis Work Group..

Published:

March 2018

Description:

The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 was published in an electronic format in July 2014 so that it could be updated as relevant changes in supporting evidence became available. The Preexposure ...

Status:

current

File Type:

[PDF - 1.67 MB]
GRADE Hepatitis A vaccine for post-exposure prophylaxis in adults >40 years of age

Personal Author:

Nelson, Noele

Corporate Author:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group..

Conference Author:

United States. Advisory Committee on Immunization Practices. Meeting (2018 February 21-22 : Atlanta, GA)

Published:

3/26/18

Series:

ACIP meeting Hepatitis Vaccines

Description:

Presentations February 2018 Day 1 : Publication date from document properties. : Hepatitis-04-Nelson-508.pdf

File Type:

[PDF - 464.63 KB]
Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy; public health service statement

Personal Author:

De Cock, Kevin M.; Holtgrave, David R.; Janssen, Robert S.; Smith, Dawn K.;

Corporate Author:

National Center for HIV, STD, and TB Prevention (U.S.), Division of HIV/AIDS Prevention--Surveillance and Epidemiology.. Centers for Disease Control and Prevention (U.S.).

Published:

September 25, 1998

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 47, no. RR-17

Description:

The most effective methods for preventing human immunodeficiency virus (HIV) infection are those that protect against exposure to HIV. Preventive behaviors include sexual abstinence, sex only with an uninfected partner, consistent and correct condom ...

File Type:

[PDF - 215.93 KB]
Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings and Technical guidance on HIV counseling

Personal Author:

Curran, James W.; Jaffe, Harold W.; Janssen, Robert S.; Ward, John W.;

Corporate Author:

National Center for Infectious Diseases (U.S.). Division of HIV/AIDS.. Centers for Disease Control and Prevention (U.S.). National Center for Prevention Services (U.S.). Division of STD/HIV Prevention..

Published:

January 15, 1993

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 42, no. RR-2

Description:

These recommendations update previous recommendations regarding human immunodeficiency virus (HIV) counseling and testing of patients in acute-care hospital settings (1). The revision was prompted by additional information regarding both the rates at...

Status:

superseded

File Type:

[PDF - 248.88 KB]